215 related articles for article (PubMed ID: 31087176)
1. Pretreatment Tattoo Marking of Suspicious Axillary Lymph Nodes: Reliability and Correlation with Sentinel Lymph Node.
Patel R; MacKerricher W; Tsai J; Choy N; Lipson J; Ikeda D; Pal S; De Martini W; Allison KH; Wapnir IL
Ann Surg Oncol; 2019 Aug; 26(8):2452-2458. PubMed ID: 31087176
[TBL] [Abstract][Full Text] [Related]
2. Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients.
Choy N; Lipson J; Porter C; Ozawa M; Kieryn A; Pal S; Kao J; Trinh L; Wheeler A; Ikeda D; Jensen K; Allison K; Wapnir I
Ann Surg Oncol; 2015 Feb; 22(2):377-82. PubMed ID: 25164040
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-Guided Fine-Needle Aspiration of Non-palpable and Suspicious Axillary Lymph Nodes with Subsequent Removal after Tattooing: False-Negative Results and Concordance with Sentinel Lymph Nodes.
Kim WH; Kim HJ; Jung JH; Park HY; Lee J; Kim WW; Park JY; Cheon H; Lee SM; Cho SH; Shin KM; Kim GC
Ultrasound Med Biol; 2017 Nov; 43(11):2576-2581. PubMed ID: 28830644
[TBL] [Abstract][Full Text] [Related]
4. Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After Treatment.
Natsiopoulos I; Intzes S; Liappis T; Zarampoukas K; Zarampoukas T; Zacharopoulou V; Papazisis K
Clin Breast Cancer; 2019 Jun; 19(3):208-215. PubMed ID: 30922804
[TBL] [Abstract][Full Text] [Related]
5. Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer.
Gatek J; Petru V; Kosac P; Ratajsky M; Duben J; Dudesek B; Jancik P; Zabojnikova M; Katrusak J; Opelova P; Podrazska L; Vazan P; Kudlova P; Holik P; Melichar B; Vrana D
Neoplasma; 2020 Nov; 67(6):1329-1334. PubMed ID: 32749847
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound guided tattooing of axillary lymph nodes in breast cancer patients prior to neoadjuvant therapy, and identification of tattooed nodes at the time of surgery.
Allweis TM; Menes T; Rotbart N; Rapson Y; Cernik H; Bokov I; Diment J; Magen A; Golan O; Levi-Bendet N; Givon Madhala O; Grubstein A
Eur J Surg Oncol; 2020 Jun; 46(6):1041-1045. PubMed ID: 31801656
[TBL] [Abstract][Full Text] [Related]
7. Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer.
Simons JM; van Pelt MLMA; Marinelli AWKS; Straver ME; Zeillemaker AM; Pereira Arias-Bouda LM; van Nijnatten TJA; Koppert LB; Hunt KK; Smidt ML; Luiten EJT; van der Pol CC
Br J Surg; 2019 Nov; 106(12):1632-1639. PubMed ID: 31593294
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-Guided Restaging and Localization of Axillary Lymph Nodes After Neoadjuvant Chemotherapy for Guidance of Axillary Surgery in Breast Cancer Patients: Experience with Activated Charcoal.
Kim WH; Kim HJ; Jung JH; Park HY; Lee J; Kim WW; Park JY; Chae YS; Lee SJ
Ann Surg Oncol; 2018 Feb; 25(2):494-500. PubMed ID: 29134374
[TBL] [Abstract][Full Text] [Related]
9. Carbon tattooing of axillary lymph nodes in breast cancer patients before neoadjuvant chemotherapy: A retrospective analysis.
Porpiglia M; Borella F; Chieppa P; Brino C; Ala A; Marra V; Castellano I; Benedetto C
Tumori; 2023 Jun; 109(3):301-306. PubMed ID: 35751383
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients.
Park S; Koo JS; Kim GM; Sohn J; Kim SI; Cho YU; Park BW; Park VY; Yoon JH; Moon HJ; Kim MJ; Kim EK
Cancer Res Treat; 2018 Jul; 50(3):801-812. PubMed ID: 28814071
[TBL] [Abstract][Full Text] [Related]
11. False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy.
de Boniface J; Frisell J; Kühn T; Wiklander-Bråkenhielm I; Dembrower K; Nyman P; Zouzos A; Gerber B; Reimer T; Hartmann S
Breast Cancer Res Treat; 2022 Jun; 193(3):589-595. PubMed ID: 35451733
[TBL] [Abstract][Full Text] [Related]
12. A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients.
Goyal A; Puri S; Marshall A; Valassiadou K; Hoosein MM; Carmichael AR; Erdelyi G; Sharma N; Dunn J; York J
Breast Cancer Res Treat; 2021 Jan; 185(2):433-440. PubMed ID: 33025481
[TBL] [Abstract][Full Text] [Related]
13. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
14. Is Regression after Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Different in Sentinel and Non-sentinel Nodes?
Cserni G; Zombori T; Andreu X; Bianchi S; Regitnig P; Amendoeira I; Balmativola D; Kovács A; Cordoba A; Reiner A; Kulka J; Kaya H; Liepniece-Karele I; Quinn C; Kővári B
Pathol Oncol Res; 2018 Jan; 24(1):167-170. PubMed ID: 28391512
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative sentinel lymph node evaluation in patients with node-positive breast cancer status post neoadjuvant systemic therapy - An institutional experience.
Laury RJ; Gloyeske N; Mettman D; Wagner JL; Fan F
Ann Diagn Pathol; 2022 Oct; 60():152012. PubMed ID: 35908331
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of preoperative tattooing of percutaneously biopsied axillary lymph node: an experimental pilot study.
Sattar AK; Ali B; Masroor I; Afzal S; Tariq MU; Idrees R; Uzzaman M; Khalid W
Pilot Feasibility Stud; 2020; 6():140. PubMed ID: 32983557
[TBL] [Abstract][Full Text] [Related]
17. Review of Novel Sentinel Lymph Node Biopsy Techniques in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
Ersoy YE; Kadioglu H
Clin Breast Cancer; 2018 Aug; 18(4):e555-e559. PubMed ID: 29429940
[TBL] [Abstract][Full Text] [Related]
18. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
19. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
Foster D; Choy N; Porter C; Ahmed S; Wapnir I
J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
[TBL] [Abstract][Full Text] [Related]
20. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
